TABLE 4.

Antifungal susceptibilities of human and wildlife C. albicans isolates

Antifungal agentEndpoint inhibition criterionIncubation time (h)Specimen originaCumulative % of isolates with MICs (μg/ml) ofb:
0.0070.0150.030.060.120.250.5124
Amphotericin BComplete48Human97.7100
Wildlife4.522.7100
CaspofunginPartial24Human9.172.797.7100
Wildlife22.781.8100
AnidulafunginPartial24Human31.865.995.5100
Wildlife27.368.295.5100
MicafunginPartial24Human59.1100
Wildlife54.595.5100
ItraconazolePartial48Human25.038.656.893.2100
Wildlife4.59.19.131.2100
PosaconazolePartial48Human6.827.352.390.9100
Wildlife9.118.295.5100
VoriconazolePartial48Human63.697.7100
Wildlife90.9100
FluconazolePartial48Human29.595.5100
Wildlife54.5100
  • a For human isolates, the number was 44; for wildlife isolates, the number was 22.

  • b —, no isolates.